MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA

BACKGROUND: Detection of glioma with MRI contrast agent is limited to cases in which the blood-brain barrier (BBB) is compromised as contrast agents cannot cross the BBB. Thus, an early-stage infiltrating tumor is not detectable. Interleukin-13 receptor alpha 2 (IL-13Rα2), which has been shown to be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Liu, Xiaoli, Madhankumar, Achuthamangalam B., Miller, Patti A., Duck, Kari A., Hafenstein, Susan, Rizk, Elias, Slagle-Webb, Becky, Sheehan, Jonas M., Connor, James R., Yang, Qing X.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Basic and Translational Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4827043/
https://ncbi.nlm.nih.gov/pubmed/26519740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov263
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados